0321 MISMATCH NEGATIVITY (MMN), EXECUTIVE FUNCTION AND SYMPTOM SEVERITY IN FIRST-EPISODE AND CHRONIC SCHIZOPHRENIA

2006 ◽  
Vol 86 ◽  
pp. S72
Author(s):  
P.B. Ward ◽  
E. Stone ◽  
L. Meyer ◽  
E. Connaughton ◽  
K. Metcalf ◽  
...  
2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S65-S65
Author(s):  
Rashina Seabury ◽  
Carrie E Bearden ◽  
Joseph Ventura ◽  
Kenneth L Subotnik ◽  
Keith H Nuechterlein ◽  
...  

Abstract Background Schizophrenia is a psychiatric disorder characterized by a deficit in reality testing, most often manifest in the form of delusions and hallucinations. Because differentiating real from imagined experiences is critically dependent on episodic and associative memory, deficits in mnemonic processes could be involved in the genesis of impaired reality testing. Prior work has shown that individuals with psychosis exhibit impairment in metamemory, or, awareness and knowledge of one’s own memory and memory processes, and that these impairments may be relevant to the emergence and/or maintenance of psychotic symptoms. Methods In the present study, we used a verbal associative memory paradigm incorporating subject confidence ratings to examine differences in metamemory processes in three separate samples: patients with chronic schizophrenia (CHR; n = 34), patients with recent-onset (first-episode) psychosis (n = 49), and individuals at clinical high risk for psychosis (n = 29) compared to control groups (n = 24, n = 26, and n = 22, respectively). We used an analysis of variance design to examine group differences in confidence gap and knowledge corruption between patients and controls. We further assessed the association of both of these metrics to symptom severity in each patient sample. Results We found that both chronic and first-episode patients displayed significantly decreased confidence gap compared to healthy controls, with patients being more confident in incorrect memory retrievals and less confident in correct memory retrievals as compared to healthy controls. Additionally, compared to healthy controls, chronic patients and first-episode patients showed significantly increased knowledge corruption (the proportion of confident incorrect memory retrievals compared to all confident retrievals). While there were no group differences in confidence gap and knowledge corruption between CHR subjects and healthy controls, decreased confidence gap was significantly correlated with positive symptom severity in CHR subjects, as well as in first-episode subjects. Discussion These findings suggest that underlying deficits in metamemory processes may possibly reflect mechanisms involved in the development and/or maintenance of disrupted reality testing in those with and at risk for psychosis.


2006 ◽  
Vol 86 ◽  
pp. S72
Author(s):  
P.B. Ward ◽  
L. Meyer ◽  
E. Stone ◽  
E. Connaughton ◽  
K. Metcalf ◽  
...  

2002 ◽  
Vol 59 (8) ◽  
pp. 686 ◽  
Author(s):  
Dean F. Salisbury ◽  
Martha E. Shenton ◽  
Carlye B. Griggs ◽  
Aaron Bonner-Jackson ◽  
Robert W. McCarley

2016 ◽  
Vol 48 (1) ◽  
pp. 3-10 ◽  
Author(s):  
Sarah M. Haigh ◽  
Brian A. Coffman ◽  
Dean F. Salisbury

Mismatch negativity (MMN) to deviant stimuli is robustly smaller in individuals with chronic schizophrenia compared with healthy controls (Cohen’s d > 1.0 or more), leading to the possibility of MMN being used as a biomarker for schizophrenia. However, there is some debate in the literature as to whether MMN is reliably reduced in first-episode schizophrenia patients. For the biomarker to be used as a predictive marker for schizophrenia, it should be reduced in the majority of cases known to have the disease, particularly at disease onset. We conducted a meta-analysis on the fourteen studies that measured MMN to pitch or duration deviants in healthy controls and patients within 12 months of their first episode of schizophrenia. The overall effect size showed no MMN reduction in first-episode patients to pitch-deviants (Cohen’s d < 0.04), and a small-to-medium reduction to duration-deviants (Cohen’s d = 0.47). Together, this indicates that pitch-deviant MMN is not a candidate biomarker for schizophrenia prediction, while duration-deviant MMN may hold some promise, albeit nearly a third as large an effect as in chronic schizophrenia. Potential causes for discrepancies between studies are discussed.


2003 ◽  
Vol 253 (4) ◽  
pp. 216-218 ◽  
Author(s):  
A. E. Simon ◽  
V. Giacomini ◽  
F. Ferrero ◽  
S. Mohr

Sign in / Sign up

Export Citation Format

Share Document